You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Sep 18, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
Jiaxing Guo1,2, Bokang Yan3, Lingshu Li1
1Department of Hematology, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University, Zhuzhou 412007, China.
Ribosomal Protein Lateral Stalk Subunit P2 (RPLP2) drives diffuse large B-cell lymphoma (DLBCL) progression by inhibiting ferroptosis. Targeting RPLP2 with Destruxin b offers a novel therapeutic strategy for DLBCL treatment.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: